4//SEC Filing
Kaplan Brett 4
Accession 0000950170-24-100633
CIK 0001768446other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 5:47 PM ET
Size
8.0 KB
Accession
0000950170-24-100633
Insider Transaction Report
Form 4
Kaplan Brett
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-08-26+465,000→ 465,000 totalExercise: $5.95Exp: 2034-08-25→ Common Stock (465,000 underlying) - Award
Restricted Stock Units
2024-08-26+77,500→ 77,500 total→ Common Stock (77,500 underlying)
Footnotes (3)
- [F1]This option was granted on August 26, 2024 (the "Grant Date"). The shares underlying the option are scheduled to vest with respect to 25% of the shares on the first anniversary of the Grant Date and the remainder are scheduled to vest in 36 equal monthly installments through August 26, 2028, subject to the Reporting Person's continued service.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
- [F3]The RSUs were granted on the Grant Date and are scheduled to vest over four years, with 25% of the shares vesting on each of the first four anniversaries of the Grant Date, subject to the Reporting Person's continued service.
Documents
Issuer
Eliem Therapeutics, Inc.
CIK 0001768446
Entity typeother
Related Parties
1- filerCIK 0001778763
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 5:47 PM ET
- Size
- 8.0 KB